Search

everythinglearnresearchcommunity

for

Search:↓

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Ixekizumab has known and some unexpected side effects.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The research found that a protein called caveolin-1 is reduced in psoriasis, but reintroducing it can help alleviate some psoriasis symptoms.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Certain gene variants can influence acne risk and severity.

Understanding acne medication chemistry helps doctors treat acne better.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

NK cells play a role in skin diseases like eczema and psoriasis.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Targeting regulatory T cells may help treat age-related diseases.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Abnormal growth factor metabolism may link psoriasis and metabolic syndrome, and obesity can affect psoriasis treatment effectiveness.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Targeting CD169+ skin macrophages may help treat psoriasis.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.